SRO Nanomedicine

Nanomedicine is the emerging sub-field of medicine where structures and tools derived from the parent field Nanotechnology are employed to develop novel and promising approaches for diagnosis, imaging, treatment and to get a better insight into molecular events involved in disease processes.

Nanotechnology brings exciting new opportunities in the medical field. Using nanostructures facilitates, for instance, molecular diagnosis. This is essential not only for early detection of diseases but also for personalized medicine, which are key-elements for a successful treatment. Furthermore, nanotechnology enables the design of smart nanopharmaceuticals for controlled, localized and targeted delivery of drugs.

Nanomedicine is an interdisciplinary field, requiring expertise from various disciplines such as medicine, engineering, chemistry, biophysics, and biology. These disciplines are virtually all present at the MESA+ Institute for Nanotechnology which is active in the development of nanosensors, miniaturized point-of-care devices, inorganic and organic nanoparticles, nanostructures, new nanomaterials, and biomolecule analysis.

The SRO Nanomedicine started in September 2009 under the lead of Pr. Serge Lemay, and from February 2012, it is headed by Dr. Séverine Le Gac.

More information can be found here about the program director.